User profiles for "author:Deepak L Bhatt"

Deepak L. Bhatt, MD, MPH, MBA

Dr. Valentin Fuster Professor of Cardiovascular Medicine, Icahn School of Medicine at …
Verified email at post.harvard.edu
Cited by 279719

Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council …

HP Adams Jr, G Del Zoppo, MJ Alberts, DL Bhatt… - Stroke, 2007 - Am Heart Assoc
Purpose—Our goal is to provide an overview of the current evidence about components of
the evaluation and treatment of adults with acute ischemic stroke. The intended audience is …

2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American …

Writing Committee Members, M Gulati, PD Levy… - Journal of the American …, 2021 - jacc.org
Aim This clinical practice guideline for the evaluation and diagnosis of chest pain provides
recommendations and algorithms for clinicians to assess and diagnose chest pain in adult …

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of …

TA Zelniker, SD Wiviott, I Raz, K Im, EL Goodrich… - The Lancet, 2019 - thelancet.com
Background The magnitude of effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i)
on specific cardiovascular and renal outcomes and whether heterogeneity is based on key …

[HTML][HTML] Dapagliflozin and cardiovascular outcomes in type 2 diabetes

SD Wiviott, I Raz, MP Bonaca… - … England Journal of …, 2019 - Mass Medical Soc
Background The cardiovascular safety profile of dapagliflozin, a selective inhibitor of sodium–
glucose cotransporter 2 that promotes glucosuria in patients with type 2 diabetes, is …

[HTML][HTML] Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

BM Scirica, DL Bhatt, E Braunwald… - … England Journal of …, 2013 - Mass Medical Soc
Background The cardiovascular safety and efficacy of many current antihyperglycemic
agents, including saxagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, are unclear …

[HTML][HTML] Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

DL Bhatt, KAA Fox, W Hacke, PB Berger… - … England Journal of …, 2006 - Mass Medical Soc
Background Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been
studied in a broad population of patients at high risk for atherothrombotic events. Methods …

[HTML][HTML] Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis

SR Ytterberg, DL Bhatt, TR Mikuls… - … England Journal of …, 2022 - Mass Medical Soc
Background Increases in lipid levels and cancers with tofacitinib prompted a trial of major
adverse cardiovascular events (MACE) and cancers in patients with rheumatoid arthritis …

[HTML][HTML] A controlled trial of renal denervation for resistant hypertension

DL Bhatt, DE Kandzari, WW O'Neill… - … England Journal of …, 2014 - Mass Medical Soc
Background Prior unblinded studies have suggested that catheter-based renal-artery
denervation reduces blood pressure in patients with resistant hypertension. Methods We …

[HTML][HTML] Rivaroxaban with or without aspirin in stable cardiovascular disease

JW Eikelboom, SJ Connolly, J Bosch… - … England Journal of …, 2017 - Mass Medical Soc
Background We evaluated whether rivaroxaban alone or in combination with aspirin would
be more effective than aspirin alone for secondary cardiovascular prevention. Methods In …

[HTML][HTML] Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia

DL Bhatt, PG Steg, M Miller, EA Brinton… - … England Journal of …, 2019 - Mass Medical Soc
Background Patients with elevated triglyceride levels are at increased risk for ischemic
events. Icosapent ethyl, a highly purified eicosapentaenoic acid ethyl ester, lowers …